Literature DB >> 6174223

Comparison of the sequences at specific sites on DNA cleaved by the antitumor antibiotics talisomycin and bleomycin.

C K Mirabelli, W G Beattie, C H Huang, A W Prestayko, S T Crooke.   

Abstract

We have investigated the site-specific cleavage of DNA by the antitumor antibiotics talisomycin and bleomycin by using 5'- or 3'-terminal 32P-labeled restriction fragments of pBR 322 DNA. Both drugs cleaved DNA preferentially at G-C and G-T sequences. However, the relative amounts of cleavage at particular cleavage sites differed between talisomycin and bleomycin at concentrations of the drugs which produced similar extents of total cleavage. In addition, talisomycin produced specific cleavages at G-A sequences which were relatively resistant to cleavage by bleomycin. Within a preferred sequence group (i.e., G-C sequences), some sites were cleaved to a greater extent relative to others by both talisomycin and bleomycin, suggesting that a greater degree of specificity than that provided by only two nucleotides is involved in the site-specific recognition and cleavage of DNA by these drugs.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174223

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  4 in total

1.  The radiomimetic enediyne C-1027 induces unusual DNA damage responses to double-strand breaks.

Authors:  Daniel R Kennedy; Terry A Beerman
Journal:  Biochemistry       Date:  2006-03-21       Impact factor: 3.162

2.  Site specificity of bleomycin cleavage in purified and intracellular simian virus 40 DNA.

Authors:  J E Grimwade; E B Cason; T A Beerman
Journal:  Nucleic Acids Res       Date:  1987-08-25       Impact factor: 16.971

3.  Quantitative measurement of single- and double-strand breakage of DNA in Escherichia coli by the antitumor antibiotics bleomycin and talisomycin.

Authors:  C K Mirabelli; C H Huang; R G Fenwick; S T Crooke
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

4.  Alteration and activation of sequence-specific cleavage of DNA by bleomycin in the presence of the antitumor drug cis-diamminedichloroplatinum(II).

Authors:  P K Mascharak; Y Sugiura; J Kuwahara; T Suzuki; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.